The assets of respiratory health company AireHealth will be auctioned off on September 13, including the patents, software, hardware and intellectual property for the company's remote patient respiratory care platform.
Florida-based Fisher Auction Company will conduct the online auction through its bidding platform.
AireHealth, founded in 2018, developed an FDA-cleared nebulizer with Bluetooth...
ex-Propeller Health CEO to advise Aevice Health's board
Singapore-based medtech company Aevice Health has appointed David Van Sickle, former CEO of mobile respiratory health firm Propeller Health, as its strategic board advisor.
According to a media release, Van Sickle, who has over 15 years of experience in digital health, will assist Aevice Health's team in developing a US commercialisation...
Stockholm-based digital health company NuvoAir has raised $12 million (€10M) to expand its chronic disease management and clinical trial platforms.
The Series A funding round was led by AlbionVC and comes off the back of a record 500% growth for NuvoAir in the first quarter of 2021.
KAYA (formerly Enern), Amino Collective and existing shareholders Spiltan, Industrifonden and Novartis Pharma AG (...
AireHealth, a Floridian startup focused on the respiratory health space, landed an FDA 510(k) clearance for its connected nebulizer VitalMed. The device was previously cleared as a stand-alone tool but did not have a connected component, according to the company.
The portable device is made of electronic vibrating mesh and is designed to nebulize medication for the inhaler at home. Patients will...
Studies on paediatric pulmonology from the UK and Sweden have demonstrated that both young and adult patients with respiratory disease can achieve good quality spirometry at home, without clinical supervision, when using the NuvoAir Home platform.
The platform includes in-app coaching which provides feedback on techniques to support quality measurements.
Other key findings show that patient...
Sweden-based digital therapeutics respiratory company, NuvoAir, has been certified as a Class Im medical device.
The NuvoAir Home platform includes Air Next, a certified bluetooth spirometer, a connected patient app and a healthcare portal.
WHY IT MATTERS
Patients can use the platform to self-monitor their respiratory health and share clinically relevant data with their care teams, who can view...
Jerusalem-based Teva Pharmaceuticals announced this week the U.S. launch of its ProAir Digihaler.
The sensor-laden albuterol dispenser requires a prescription, and is indicated for those aged four years or older with reversible obstructive airway diseases such as asthma and COPD, as well as for the prevention of exercise-induced bronchospasm (EIB) among this same group.
The device connects to a...
AireHealth, maker of an FDA-cleared portable nebulizer that pairs with a smartphone app for remote monitoring, announced Friday the acquisition of fellow respiratory health company BreathResearch. Financial terms of the deal were not disclosed.
The merger agreement sees AireHealth adding BreathResearch's IP, research and patents, which include work on machine learning analytics for respiratory...
Digital respiratory health company Propeller Health has received 510(k) clearance for a sensor and app intended for use with AstraZeneca's Symbicort inhaler for asthma and COPD, the company announced today.
The tool – which, according to the agency, was submitted to the agency in September and greenlit in late March – was developed in a previously unannounced partnership with the Cambridge,...
Respiratory monitor maker NuvoAir (formerly Pond Healthcare Innovation) has picked up its first FDA 510(k) for Air Next, a portable and connected home-use spirometer device.
According to the FDA’s premarket notification database, the Stockholm, Sweden-based company submitted its application in November 2018, and received the decision last Thursday.
The Air Next is designed for patients with...
